(Q33497875)

English

The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

based on heuristic

inferred from title

author name string

Cabral AR

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Amigo MC

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Cabiedes J

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Alarcon-Segovia D

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

language of work or name

0 references

publication date

1 November 1996

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

American Journal of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

101

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

472-481

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Phospholipid specificity and requirement of beta 2-glycoprotein-I for reactivity of antibodies from patients with primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Hemolytic anemia related to an IgM autoantibody to phosphatidylcholine that binds in vitro to stored and to bromelain-treated human erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Simple microassay of protein with membrane filter

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Anticardiolipin antibodies: isotype distribution and phospholipid specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Activated protein C resistance phenotype and genotype in patients with primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

A Sensitive Test Demonstrating Lupus Anticoagulant and its Behavioural Patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Amino acid sequence and location of the disulfide bonds in bovine .beta.2 glycoprotein I: the presence of five Sushi domains

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Molecular studies on phospholipid-binding sites and cryptic epitopes appearing on beta 2-glycoprotein I structure recognized by anticardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Binding of beta 2-glycoprotein I to platelets: effect of adenylate cyclase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Resistance to activated protein C activity of an anti-beta 2-glycoprotein I antibody in the presence of beta 2-glycoprotein I.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Lupus-like anticoagulant properties of murine monoclonal antibodies to beta 2-glycoprotein I

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

PERIPHERAL VASCULAR SYNDROMES ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Presence of serum antibodies to coagulation protein C in patients with systemic lupus erythematosus is not associated with antigenic or functional protein C deficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Natural autoantibodies are involved in the haemolytic anaemia of NZB mice

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900254-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9343(96)00254-9

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33497875&oldid=1535812973"